Clinical Report: Who's Topping the Digital Charts?

Overview

The KLAS report on digital pathology highlights the slow adoption of digital technologies among US healthcare providers, with only 15% currently utilizing digital pathology. The report emphasizes the need for independent assessments to bridge the gap between vendor claims and actual performance.

Background

Digital pathology and AI represent significant advancements in laboratory medicine, yet their adoption remains limited, particularly in the US. With only a fraction of healthcare providers fully utilizing these technologies, understanding product reliability and performance is crucial for informed decision-making. KLAS aims to provide essential benchmarking data to assist lab leaders in navigating this emerging market.

Data Highlights

No numerical data provided in the source material.

Key Findings

Clinical Implications

Healthcare providers should consider KLAS reports when evaluating digital pathology solutions to ensure they make informed purchasing decisions. Understanding the barriers to adoption can help institutions develop strategies to facilitate the transition to digital workflows.

Conclusion

The KLAS report underscores the importance of independent assessments in the digital pathology market, highlighting both the potential for growth and the challenges that remain in achieving widespread adoption.

Related Resources & Content

1. KLAS Research, Digital Pathology 2026, 2023 -- Digital Pathology Market Insights
2. College of American Pathologists, CAP Guidelines, 2023 -- WSI Validation Guideline Update
3. PR Newswire, 2024 -- Leica Biosystems Receives FDA Clearance for Digital Pathology System
4. Eyecare Business — THE FUTURE IS NOW
5. Eyecare Business — Summer Hit
6. Eyecare Business — LAST WORD
7. Eyecare Business — Who's Shopping on the Net?
8. validating whole slide imaging for diagnostic purposes in pathology: guideline update summary of recommendations
9. Leica Biosystems Receives FDA 510(k) Clearance for Aperio GT 450 DX Digital Pathology System with both SVS and Native DICOM
10. Artificial Intelligence-Enabled Medical Devices | FDA
11. Prospective Clinical Implementation of Paige Prostate Detect Artificial Intelligence Assistance in the Detection of Prostate Cancer in Prostate Biopsies: CONFIDENT P Trial Implementation of Artificial Intelligence Assistance in Prostate Cancer Detection | JCO Clinical Cancer Informatics